Download PDF
Pharmacopsychiatry 2002; 35(2): 77-78
DOI: 10.1055/s-2002-25025
Case Report
© Georg Thieme Verlag Stuttgart · New York

Sexual Dysfunction Caused by Reboxetine

E.  M.  Haberfellner
  • 1Linz, Austria
Further Information

Publication History

22. 5. 2001

10. 7. 2001

Publication Date:
12 April 2002 (online)

Also available at
    Permissions and Reprints

The autor reports on self-experienced, reboxetine-induced sexual dysfunction (prolonged orgasm of reduced intensity) and seminal emission after defecation. Both disorders were accompanied by pain and ceased within two days after discontinuation of the drug.

References

  • 1 Breier A, Ginsberg E M, Dennis S C. Seminal emission induced by tricyclic antidepressant.  Am J Psychiatry. 1984;  141 610-611
    PubMedGoogle Scholar
  • 2 Gutierrez M A, Stimmel G L. Management of and counceling for psychotropic drug-induced sexual dysfunction.  Pharmacotherapy. 1999;  19 (7) 823-831
    CrossrefPubMedGoogle Scholar
  • 3 Montgomery S A. Predicting response: noradrenaline reuptake inhibition.  Int Clin Psychopharmacol. 1999;  14 (11) S21-26
    PubMedGoogle Scholar
  • 4 O'Flynn R, Michael A. Reboxetine-induced spontaneous ejaculation.   Br J Psychiatry. 2000;  177 567-568
    CrossrefPubMedGoogle Scholar
  • 5 Rothschild A J. Sexual side effect of antidepressants.  J Clin Psychiatry. 2000;  61 (1) S28-S36
    PubMedGoogle Scholar
  • 6 Versiani M, Amin M, Chouinard G. Double-blind, placebo-controlled study with Reboxetine in inpatients with severe major depressive disorder.  J Clin Psychopharmacol. 2000;  20 28-34
    CrossrefPubMedGoogle Scholar

MD Egon Michael Haberfellner

Friedrichstrasse 14

4040 Linz

Austria

Email: e.m.haberfellner@aon.at